The role of prelamin A post-translational maturation in stress response and 53BP1 recruitment.
53BP1
DNA damage repair
Hutchinson-Gilford Progeria Syndrome (HGPS)
lamin A/C
laminopathies
oxidative stress response
prelamin A
premature ageing
Journal
Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250
Informations de publication
Date de publication:
2022
2022
Historique:
received:
12
08
2022
accepted:
24
10
2022
entrez:
5
12
2022
pubmed:
6
12
2022
medline:
6
12
2022
Statut:
epublish
Résumé
Lamin A is a main constituent of the nuclear lamina and contributes to nuclear shaping, mechano-signaling transduction and gene regulation, thus affecting major cellular processes such as cell cycle progression and entry into senescence, cellular differentiation and stress response. The role of lamin A in stress response is particularly intriguing, yet not fully elucidated, and involves prelamin A post-translational processing. Here, we propose prelamin A as the tool that allows lamin A plasticity during oxidative stress response and permits timely 53BP1 recruitment to DNA damage foci. We show that while PCNA ubiquitination, p21 decrease and H2AX phosphorylation occur soon after stress induction in the absence of prelamin A, accumulation of non-farnesylated prelamin A follows and triggers recruitment of 53BP1 to lamin A/C complexes. Then, the following prelamin A processing steps causing transient accumulation of farnesylated prelamin A and maturation to lamin A reduce lamin A affinity for 53BP1 and favor its release and localization to DNA damage sites. Consistent with these observations, accumulation of prelamin A forms in cells under basal conditions impairs histone H2AX phosphorylation, PCNA ubiquitination and p21 degradation, thus affecting the early stages of stress response. As a whole, our results are consistent with a physiological function of prelamin A modulation during stress response aimed at timely recruitment/release of 53BP1 and other molecules required for DNA damage repair. In this context, it becomes more obvious how farnesylated prelamin A accumulation to toxic levels alters timing of DNA damage signaling and 53BP1 recruitment, thus contributing to cellular senescence and accelerated organismal aging as observed in progeroid laminopathies.
Identifiants
pubmed: 36467410
doi: 10.3389/fcell.2022.1018102
pii: 1018102
pmc: PMC9709412
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1018102Informations de copyright
Copyright © 2022 Capanni, Schena, Di Giampietro, Montecucco, Mattioli and Lattanzi.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nat Commun. 2018 Apr 27;9(1):1700
pubmed: 29703891
Oncotarget. 2015 Oct 6;6(30):29914-28
pubmed: 26359359
Circulation. 2010 May 25;121(20):2200-10
pubmed: 20458013
Circ Res. 2013 May 10;112(10):e99-109
pubmed: 23564641
Physiol Genomics. 2005 Oct 17;23(2):150-8
pubmed: 16046620
Hum Mol Genet. 2005 Jun 1;14(11):1489-502
pubmed: 15843404
Aging Cell. 2021 Jan;20(1):e13285
pubmed: 33393189
Genes Dev. 2021 Oct 1;35(19-20):1356-1367
pubmed: 34503990
Front Cell Dev Biol. 2019 Jan 31;7:6
pubmed: 30766871
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13558-63
pubmed: 23901102
Cells. 2019 Oct 18;8(10):
pubmed: 31635416
J Cell Sci. 2016 May 15;129(10):1975-80
pubmed: 27034136
Cell Mol Life Sci. 2005 Nov;62(22):2669-78
pubmed: 16261260
Sci Adv. 2021 Aug 27;7(35):
pubmed: 34452908
Mol Cell. 2011 Aug 19;43(4):649-62
pubmed: 21855803
Environ Mol Mutagen. 2020 Aug;61(7):680-692
pubmed: 31983077
Nucleus. 2018 Jan 1;9(1):258-275
pubmed: 29637811
Cells. 2020 Jun 06;9(6):
pubmed: 32517247
Sci Rep. 2016 Jul 27;6:30325
pubmed: 27461848
Cell Cycle. 2012 Oct 1;11(19):3568-77
pubmed: 22935701
Proc Natl Acad Sci U S A. 2022 Mar 1;119(9):
pubmed: 35197292
Nucleus. 2014 Sep-Oct;5(5):427-40
pubmed: 25482195
Front Cell Dev Biol. 2022 May 26;10:913458
pubmed: 35693945
Ageing Res Rev. 2020 Sep;62:101073
pubmed: 32446955
Aging Cell. 2015 Apr;14(2):162-9
pubmed: 25645366
Aging (Albany NY). 2013 Jun;5(6):445-59
pubmed: 23804595
Oncotarget. 2016 Mar 29;7(13):15662-77
pubmed: 26701887
Aging (Albany NY). 2014 Sep;6(9):755-70
pubmed: 25324471
J Biol Chem. 2017 Apr 7;292(14):5992-6003
pubmed: 28255090
Cells. 2022 Jun 05;11(11):
pubmed: 35681541
JAMA. 2018 Apr 24;319(16):1687-1695
pubmed: 29710166
Expert Opin Ther Targets. 2022 May;26(5):393-399
pubmed: 35575136
Aging Cell. 2018 Oct;17(5):e12824
pubmed: 30109767
DNA Repair (Amst). 2010 Apr 4;9(4):358-64
pubmed: 20060369
Genome Res. 2017 Jul;27(7):1126-1138
pubmed: 28424353
Aging Cell. 2016 Dec;15(6):1039-1050
pubmed: 27464478
Nat Commun. 2022 Jan 13;13(1):321
pubmed: 35027552
Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13432-7
pubmed: 17652517
Cell Death Differ. 2011 Aug;18(8):1305-15
pubmed: 21311568
Cell Cycle. 2010 Dec 1;9(23):4766-8
pubmed: 21127399
EMBO J. 2011 Jul 12;30(16):3383-96
pubmed: 21750527
Cell Cycle. 2014;13(23):3628-35
pubmed: 25483060
Int J Mol Sci. 2022 Jun 24;23(13):
pubmed: 35806061
Cell Cycle. 2003 Nov-Dec;2(6):596-603
pubmed: 14504476
Basic Clin Pharmacol Toxicol. 2022 Oct;131(4):217-223
pubmed: 35790078
Eur J Histochem. 2009 Jan-Mar;53(1):43-52
pubmed: 19351612
Exp Cell Res. 2008 Feb 1;314(3):453-62
pubmed: 18093584
Oncotarget. 2016 May 24;7(21):30018-31
pubmed: 27145372
J Cell Biochem. 2007 Dec 1;102(5):1149-59
pubmed: 17654502
Cell Rep. 2018 Feb 20;22(8):2006-2015
pubmed: 29466729
Int J Mol Sci. 2019 Oct 23;20(21):
pubmed: 31652739